Answers are grounded in this paper and cite their sources.
Major Depressive disorder (MDD) is the most common comorbidity with obsessive-compulsive disorder (OCD); more than 50% of OCD patients meet lifetime criteria for MDD or dysthymia [1]. Depression can significantly worsen OCD treatment outcomes [2] and elevate the risk for suicide [3]. While the multi-center-tested and FDA indicated deep transcranial magnetic stimulation (dTMS) treatment for OCD uses the H7 coil to target dorsomedial prefrontal cortex (dmPFC) and anterior cingulate cortex (ACC) [4], the treatment for MDD uses the H1 coil to target the dorsolateral prefrontal cortex (dlPFC) bilaterally with preference to the left [5].
No takes yet. Share an insight, caveat, or question.
Harmelech et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: